[1]Arzneimittel-Forschung/DrugResearch,2006,vol.56,p.631-639
115840-34-1
1477-57-2
14368-26-4
1440-60-4
20266-00-6
23511-50-4
55687-05-3 | 2,5-Dichloroquinoxaline | AA00DHRW | MFCD11846477
51746-83-9 | 2-Amino-1-(pyridin-4-yl)ethanone dihydrochloride | AA00DHV2 | MFCD09260970
51012-29-4 | 2-(4-Bromo-benzenesulfonylamino)-benzoic acid | AA00DICF | MFCD00583502
55130-40-0 | Ethyl 3,4-dioxopentanoate | AA00DIKN | MFCD24689591
493038-85-0 | (2Z)-3-(Dimethylamino)-2-pyridin-2-ylacrylonitrile | AA00DIWA | MFCD01570039
478647-20-0 | 3-Boc-9-oxa-3,7-diazabicyclo[3.3.1]nonane | AA00DJ77 | MFCD17016710
4786-24-7 | 3-METHYLCROTONONITRILE | AA00DJJV | MFCD00040421
474708-98-0 | 6-Bromoimidazo[1,2-a]pyridine-3-carbonitrile | AA00DJQD | MFCD11858502
460087-82-5 | Methyl 3-iodoimidazo[1,2-a]pyridine-6-carboxylate | AA00DK1M | MFCD07021385
52415-10-8 | 3-Bromo-6-nitrodurene | AA00DKCQ | MFCD01463901